These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 1316065

  • 21. Photocleavage of DNA by the fluoroquinolone antibacterials.
    Martínez L, Chignell CF.
    J Photochem Photobiol B; 1998 Aug 21; 45(1):51-9. PubMed ID: 9819899
    [Abstract] [Full Text] [Related]

  • 22. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
    Wise R, Griggs D, Andrews JM.
    Rev Infect Dis; 1988 Aug 21; 10 Suppl 1():S83-9. PubMed ID: 3162327
    [Abstract] [Full Text] [Related]

  • 23. Renal clearance of lomefloxacin is decreased by furosemide.
    Sudoh T, Fujimura A, Shiga T, Sasaki M, Harada K, Tateishi T, Ohashi K, Ebihara A.
    Eur J Clin Pharmacol; 1994 Aug 21; 46(3):267-9. PubMed ID: 8070509
    [Abstract] [Full Text] [Related]

  • 24. Clinical pharmacokinetics of the newer antibacterial 4-quinolones.
    Neuman M.
    Clin Pharmacokinet; 1988 Feb 21; 14(2):96-121. PubMed ID: 3282749
    [Abstract] [Full Text] [Related]

  • 25. A review of the pharmacokinetic profile of temafloxacin.
    Dudley MN.
    J Antimicrob Chemother; 1991 Dec 21; 28 Suppl C():55-64. PubMed ID: 1664830
    [Abstract] [Full Text] [Related]

  • 26. Temafloxacin pharmacokinetics in subjects with normal and impaired renal function.
    Granneman GR, Braeckman R, Kraut J, Shupien S, Craft JC.
    Antimicrob Agents Chemother; 1991 Nov 21; 35(11):2345-51. PubMed ID: 1666497
    [Abstract] [Full Text] [Related]

  • 27. Effect of ranitidine on renal clearance of lomefloxacin.
    Sudoh T, Fujimura A, Harada K, Sunaga K, Ohmori M, Sakamoto K.
    Eur J Clin Pharmacol; 1996 Nov 21; 51(1):95-8. PubMed ID: 8880059
    [Abstract] [Full Text] [Related]

  • 28. Anti-Mycobacterium leprae activity of several quinolones studied in the mouse.
    Pattyn SR.
    Int J Lepr Other Mycobact Dis; 1991 Dec 21; 59(4):613-7. PubMed ID: 1666402
    [Abstract] [Full Text] [Related]

  • 29. Effects of temafloxacin and ciprofloxacin on the pharmacokinetics of caffeine.
    Mahr G, Sörgel F, Granneman GR, Kinzig M, Muth P, Patterson K, Fuhr U, Nickel P, Stephan U.
    Clin Pharmacokinet; 1992 Dec 21; 22 Suppl 1():90-7. PubMed ID: 1319876
    [Abstract] [Full Text] [Related]

  • 30. Quantitative comparison of the convulsive activity of combinations of twelve fluoroquinolones with five nonsteroidal antiinflammatory agents.
    Kim J, Ohtani H, Tsujimoto M, Sawada Y.
    Drug Metab Pharmacokinet; 2009 Dec 21; 24(2):167-74. PubMed ID: 19430173
    [Abstract] [Full Text] [Related]

  • 31. Comparative penetration of lomefloxacin and other quinolones into human phagocytes.
    Perea EJ, García I, Pascual A.
    Am J Med; 1992 Apr 06; 92(4A):48S-51S. PubMed ID: 1316071
    [Abstract] [Full Text] [Related]

  • 32. Photogeneration of fluoride by the fluoroquinolone antimicrobial agents lomefloxacin and fleroxacin.
    Martinez LJ, Li G, Chignell CF.
    Photochem Photobiol; 1997 Mar 06; 65(3):599-602. PubMed ID: 9077147
    [Abstract] [Full Text] [Related]

  • 33. Pharmacokinetics of temafloxacin in humans after multiple oral doses.
    Granneman GR, Carpentier P, Morrison PJ, Pernet AG.
    Antimicrob Agents Chemother; 1992 Feb 06; 36(2):378-86. PubMed ID: 1318680
    [Abstract] [Full Text] [Related]

  • 34. [Comparative pharmacokinetics of lomefloxacin and other fluoroquinolones].
    Iakovlev VP.
    Antibiot Khimioter; 1998 Feb 06; 43(10):46-52. PubMed ID: 9825111
    [No Abstract] [Full Text] [Related]

  • 35. In vitro activity of nine fluoroquinolone antibiotics against 200 strains of enterococci.
    Murray PR, Bratcher JL, Niles AC, Hampton CM.
    Diagn Microbiol Infect Dis; 1993 Jan 06; 16(1):83-5. PubMed ID: 8425382
    [Abstract] [Full Text] [Related]

  • 36. In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.
    Barry AL, Jones RN.
    J Antimicrob Chemother; 1989 Apr 06; 23(4):527-35. PubMed ID: 2745259
    [Abstract] [Full Text] [Related]

  • 37. Comparative pharmacokinetics of new quinolones.
    Lode H, Höffken G, Prinzing C, Glatzel P, Wiley R, Olschewski P, Sievers B, Reimnitz D, Borner K, Koeppe P.
    Drugs; 1987 Apr 06; 34 Suppl 1():21-5. PubMed ID: 3481323
    [Abstract] [Full Text] [Related]

  • 38. Overview of the fluoroquinolone antibiotics.
    Just PM.
    Pharmacotherapy; 1993 Apr 06; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
    [Abstract] [Full Text] [Related]

  • 39. Activity of nine fluoroquinolones against strains of Bordetella bronchiseptica.
    Carbone M, Fera MT, Pennisi MG, Masucci M, De Sarro A, Macrì C.
    Int J Antimicrob Agents; 1999 Aug 06; 12(4):355-8. PubMed ID: 10493613
    [Abstract] [Full Text] [Related]

  • 40. Quinolone disposition in the elderly. Practical implications.
    Nilsson-Ehle I, Ljungberg B.
    Drugs Aging; 1991 Aug 06; 1(4):279-88. PubMed ID: 1794020
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.